News

06 Sep 2017

Patent granted in Europe

European patent office (EPO) has granted the patent application regarding the company technology and the patent has now…

06 Sep 2017

Ectin research second issue of shares amounting to a value of 1.5 million SEK was completed in July…

22 Feb 2017

Ectin Research has been selected by the European Commission as the winner of HORIZON 2020 “Phase 1” –…

23 Dec 2016

The company was recently granted additional “Såddfinansiering” to support the development of bladder cancer therapy.

26 Oct 2016

Meet the company at BIO-Europe, one of the main events for partnering and drug development, this year in…

22 Jun 2016

VINNOVA through Sahlgrenska Science Park supports Ectin Research business developmental activities by rewarding the company 100 000 SEK…

13 Apr 2016

Next phase of product development of MFA-370 against severe bladder cancer is initiated by Ectin research. An experienced…

26 Feb 2016

Ectin research first issue of shares amounting to a value of 3 million SEK is completed and the…

15 Oct 2015

The company announces the appointment of Michael Oredsson as chairman of Ectin Research. He is currently CEO of…

18 Jun 2015

“Såddfinansiering” was granted to the company to support the company’s development of bladder cancer therapy.